12931_2017_583_MOESM1_ESM.docx (288.3 kB)
Additional file 1: of Reduction in clinically important deterioration in chronic obstructive pulmonary disease with aclidinium/formoterol
journal contribution
posted on 2017-05-30, 05:00 authored by Dave Singh, Anthony DâUrzo, Ferran Chuecos, Anna MuĂąoz, Esther Garcia GilSensitivity analysis of the risk of CID events for common visits, characterization of patients according to CID endpoints achieved and analysis of the risk of CID events over 24Â weeks, stratified by ICS use, previous treatment, and symptoms. (DOCX 289 kb)